Insider Trading Activity Acorda Therapeutics Inc (NASDAQ:ACOR) – Insider Sold 31,000 shares of Stock

ME Staff

6 years ago

Insider Trading Activity For Acorda Therapeutics Inc (NASDAQ:ACOR)

David Lawrence , Insider of Acorda Therapeutics Inc (NASDAQ:ACOR) reportedly Sold 31,000 shares of the company’s stock at an average price of 27.58 for a total transaction amount of $854,980.00 SEC Form

Insider Trading History For Acorda Therapeutics Inc (NASDAQ:ACOR)

On 11/13/2012 Sandra Phd Panem, Director, sold 22,569 with an average share price of $24.12 per share and the total transaction amounting to $544,364.28.

On 12/3/2012 Ron Cohen, CEO, sold 16,407 with an average share price of $24.22 per share and the total transaction amounting to $397,377.54.

On 12/3/2012 David Lawrence, CFO, sold 9,313 with an average share price of $24.21 per share and the total transaction amounting to $225,467.73.

On 12/3/2012 Andrew Blight, Insider, sold 7,200 with an average share price of $24.20 per share and the total transaction amounting to $174,240.00.

On 12/4/2012 Lauren M Sabella, VP, sold 4,364 with an average share price of $24.58 per share and the total transaction amounting to $107,267.12.

On 5/8/2013 Sandra Phd Panem, Director, sold 10,000 with an average share price of $33.80 per share and the total transaction amounting to $338,000.00.

On 6/10/2013 Ron Cohen, CEO, sold 11,000 with an average share price of $34.15 per share and the total transaction amounting to $375,650.00.

Analyst Ratings History For Acorda Therapeutics Inc (NASDAQ:ACOR)

On 6/1/2016 Aegis Boost Price Target of rating Buy with a price target of $40.00 to $52.00
On 1/8/2017 Evercore ISI Set Price Target of rating Hold with a price target of $23.00
On 10/6/2017 Goldman Sachs Group Reiterated Rating Sell to Sell with a price target of $20.00
On 11/1/2017 Jefferies Group Boost Price Target of rating Hold with a price target of $22.00 to $25.00
On 11/9/2017 CIBC Initiated Coverage of rating Market Perform to Market Perform
On 11/15/2017 Cantor Fitzgerald Lower Price Target of rating Neutral with a price target of $18.00 to $16.00
On 11/15/2017 Oppenheimer Set Price Target of rating Hold with a price target of $18.00

Recent Trading Activity for Acorda Therapeutics Inc (NASDAQ:ACOR)
Shares of Acorda Therapeutics Inc closed the previous trading session at 27.20 +0.00 0.00% with 3981300 shares trading hands.